ArticleBMJ (Clinical research ed.)2004
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.
Article in BMJ (Clinical research ed.), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1,148 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Multicentre Study of Low Dose Oral Vitamin K for INR Control in Patients Receiving Warfarin
National Institute of Health Research (NIHR) Global Health Research Group on Warfarin Anticoagulation in Patients with Cardiovascular Disease in Sub-Saharan Africa
The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults
Who cites it
1,148 citing papers in PubMed, 8 syntheses or guidelines pooled it.
- The association between age and medication-related hospital admission in adults: a systematic review and meta-analysis.International journal of clinical pharmacy · 2026Pooled it
- Realist review: understanding the challenges of medicine optimisation among older people from ethnic minority communities with polypharmacy in primary care.BMC geriatrics · 2025Pooled it
- Improving adverse drug event reporting by healthcare professionals.The Cochrane database of systematic reviews · 2024Pooled it
- Factors associated with underreporting of adverse drug reactions by patients: a systematic review.International journal of clinical pharmacy · 2023Pooled it
- Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review.BMC health services research · 2023Pooled it
- Medicines Related Problems (MRPs) Originating in Primary Care Settings in Older Adults - A Systematic Review.Journal of pharmacy practice · 2023Pooled it
- Prevalence of Drug-Drug Interactions in Older Community-Dwelling Individuals: A Systematic Review and Meta-analysis.Drugs & aging · 2023 · on this mapPooled it
- The effects of pharmaceutical interventions on potentially inappropriate medications in older patients: a systematic review and meta-analysis.Frontiers in public health · 2023Pooled it
- Comparing In-Person Versus Self-Paced Polypharmacy Education in Older Adults: A Pragmatic Comparison of Delivery Format Effectiveness.Journal of the American Geriatrics Society · 2026Trial
- Trial
- Web application for assisting non-dermatology physicians in learning and managing patients with common cutaneous adverse drug reactions: a multicenter randomized controlled trial.Annals of medicine · 2024Trial
- Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People.Journal of the American Heart Association · 2024Trial
- Digital Medication Management in Polypharmacy—Findings of a Cluster-Randomized, Controlled Trial With a Stepped-Wedge Design in Primary Care Practices (AdAM).Deutsches Arzteblatt international · 2024Trial
- Lived experience of people with lateral elbow tendinopathy: a qualitative study from the OPTimisE pilot and feasibility trial.BMJ open · 2023Trial
- Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations.European journal of clinical pharmacology · 2023Trial
- Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy.International journal of clinical pharmacy · 2023Trial
- High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study.Annals of medicine · 2026Article
- Cohort Profile Update: The Adverse Events Questionnaire of Medications and Vaccines (ADE-Q) in the Estonian Biobank.International journal of epidemiology · 2026Article
- Mapping Pharmacogenomic Determinants of Adverse Drug Reactions in Hypertension: A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Computational Prediction of the Severity of Adverse Drug Reactions Caused by Drug-Drug Interactions.Pharmaceuticals (Basel, Switzerland) · 2026Article
1,088 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo ascertain the current burden of adverse drug reactions (ADRs) through a prospective analysis of all admissions to hospital.
designProspective observational study.
settingTwo large general hospitals in Merseyside, England.
participants18 820 patients aged > 16 years admitted over six months and assessed for cause of admission.
main outcome measuresPrevalence of admissions due to an ADR, length of stay, avoidability, and outcome.
resultsThere were 1225 admissions related to an ADR, giving a prevalence of 6.5%, with the ADR directly leading to the admission in 80% of cases. The median bed stay was eight days, accounting for 4% of the hospital bed capacity. The projected annual cost of such admissions to the NHS is 466m pounds sterling (706m Euros, 847m dollars). The overall fatality was 0.15%. Most reactions were either definitely or possibly avoidable. Drugs most commonly implicated in causing these admissions included low dose aspirin, diuretics, warfarin, and non-steroidal anti-inflammatory drugs other than aspirin, the most common reaction being gastrointestinal bleeding.
conclusionThe burden of ADRs on the NHS is high, accounting for considerable morbidity, mortality, and extra costs. Although many of the implicated drugs have proved benefit, measures need to be put into place to reduce the burden of ADRs and thereby further improve the benefit:harm ratio of the drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.